RE:RE:What are the known milestones --Yes Bob, as Scott said, Pierre has been hinting repeatedly at a first licensing deal as of late. I expect one or two of these with enough upfront and details to extrapolate the target WW expected market will do good. All these last trips to Japan, Boston and this week, London, will end upgiving results at some point.
One other thing I'm looking forward with great anticipation is the pre-IND meeting for Pg-Wound with the FDA and IND filing. If it goes anywhere as easy as that of Pg-CPD, I suggest it could make a big splash (that's worth 5B$ of sales after all! that might be very short distanced!) !!!
And you obviously already mentionned it but I think the very own IND filings that you listed due in H1 2016, for 4050 of course, but above all for PPPS proteins will have some interesting effect on Mr Market. Cause there's a lot of value piled there and well on its way. Each will have analyst upgrade their target.
Thus I also expect Mr Market to slowly wake up to the low-risk really broad nature of the PPPS proteins portfolio in the next two quarters.
The word is out already. And the clock is ticking. Their position build up by the different already well informed accounts alone should go a long way to have the needle move in the right direction.
All IMHO
:-)
FD